<http://schema.org/description>
"The first few months of 2009 have been among the most auspicious for stem-cell research since the field's inception. In January, the Palo Alto&amp;ndash;based biotech firm Geron Corporation announced it had received U.S. Food and Drug Administration approval to begin clinical trials of a stem-cell&amp;ndash;based spinal cord therapy in humans."^^<http://www.w3.org/2001/XMLSchema#string>
<http://archives.sfweekly.com/sanfrancisco/stem-cell-stalemate-the-push-for-cures-may-produce-only-disappointment-or-worse/Content?oid=2172163>